Navigation Links
ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ending December 31, 2011
Date:4/2/2012

valents of approximately $215,000.

Revenues

Revenues for the fourth quarter of 2011 were $256,000, compared to $1,029,000 for the fourth quarter of 2010.  The decrease of approximately $773,000 in revenues from the fourth quarter of 2010 compared to the fourth quarter of 2011 was primarily due to decreased licensing fees as the prior year included the recognition of $751,000 in unamortized licensing fees.

For the year ending December 31, 2011, revenues were $485,000, compared to $1,557,000 for the same period of 2010.  The decrease of approximately $1,072,000 was due primarily to the following factors; a reduction of $988,000 in OraDisc™ related licensing fees and a decrease of $186,000 in Zindaclin® related licensing and royalty fees due to our divestiture of this product in September 2010, this was partially offset by increased product sales.

Research and Development

Research and development expenses for the fourth quarter of 2011 were $198,000, including $17,000 in share-based compensation, compared to $309,000, including $32,000 in share-based compensation, for the fourth quarter of 2010.  The decrease of approximately $111,000 in research and development expenses was primarily was due primarily to lower costs for direct research costs of $85,000.

For the year ending December 2011, research and development expenses were $950,000, including $70,000 in share-based compensation, compared to $1,260,000, including $136,000 in share-based compensation, for the same period in 2010. The decrease of approximately $311,000 in research and development expenses was due primarily to lower costs for regulatory fees of $140,000, direct research costs of $73,000, clinical testing costs for our wound care technologies of $46,000 and scientific compensation costs of $30,000.

Selling, general and administrative

Selling, general and administrative expenses for the fourth quarter o
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. ULURU Inc. Reports Third Quarter 2010 Financial Results
10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
(Date:6/19/2013)... BETHESDA, Md. , June 19, 2013 /PRNewswire/ -- ... "Company"), an American healthcare company providing services in ... of United Family Healthcare, a network of private ... official opening of its Beijing United Family Rehabilitation ... development projects of the United Family Healthcare ("UFH") ...
(Date:6/19/2013)... -- BD Biosciences, a segment of BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... of high-performance research flow cytometers. The BD ... most compact footprint in its class at just 30" x ... (76.2 cm). Recognizing that space is a valuable commodity in ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... Arbor, Mich. Children had half as many ... evening office hours on five or more days a ... at C.S. Mott Children,s Hospital and Johns Hopkins University. ... in The Journal of Pediatrics and will ... "These findings are an important step in understanding where ...
(Date:6/19/2013)... no-strings sexual encounters are increasingly common on college ... others to "hook up"? A new study by ... and Preventive Medicine, published online by the ... certain factors and behaviors associated with sexual hookups, ... the potential for negative emotional and physical health ...
(Date:6/19/2013)... for repairing damage to the genetic material DNA become ... seem, those compounds are sparking optimism as potential treatments ... in BRCA, a gene that made headlines when actress ... termed PARP inhibitors, are the topic of the cover ... Engineering News . C&EN is the weekly news magazine ...
(Date:6/19/2013)... Center and colleagues at Louisiana State University have developed ... immediate therapy. It relies on understanding the genetic interaction ... better predict a prostate cancer,s aggressiveness to avoid unnecessary ... the online journal PLOS ONE in April. ... 20 percent of all cancers and 9 percent of ...
Breaking Medicine News(10 mins):Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... investigators say , MONDAY, July 6 (HealthDay News) -- ... that help breast cancer cells survive in the bone marrow ... the July issue of the journal Cancer Cell , ... according to the researchers. , "We sought to identify signaling ...
... study suggests, , MONDAY, July 6 (HealthDay News) -- Children ... diabetes, rheumatoid arthritis and celiac disease have up to ... finds. , Although the association between autism and a maternal ... found in earlier research, the researchers behind the new study ...
... Every year as many as seven million adults in ... systematic review of the scientific literature on delirium prevention ... the Regenstrief Institute and Wishard Health Services found that ... for hospitalized adults, no effective way to prevent or ...
... study to determine the non-medical factors that may be ... researchers at Columbia University Mailman School of Public Health ... of chemotherapy in elderly women with breast cancer and ... if treated by oncologists employed in a private practice. ...
... , IRVINE, Calif., July 6 Quest International, Inc. announced ... Healthcare,s Best Global Supplier of the Year Award. This ... presented with the award, receiving honors in 2006 as well. ... 2009 Siemens Annual Supplier Conference. Quest was selected for ...
... of one of the nation,s largest Medicare chronic condition special ... care for seniors with chronic illness, today announced the appointment ... effective August 1, 2009. , , Prior to ... CEO of United HealthCare,s Evercare healthplans, the business unit that ...
Cached Medicine News:Health News:Research Reveals Clues to Breast Cancer's Spread 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 3Health News:Autism May Be Linked to Mom's Autoimmune Disease 4Health News:Delirium in hospitalized adults: Situation critical, no relief available 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 3Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 2Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 3Health News:Dr. John Mach Appointed Chief Medical Officer at XLHealth 2
... HRR 4th edition pseudoisochromatic test from Richmond ... screener plates and the 14 diagnostic series for ... plates has its own tab for easy and ... set of instructions in English and a laminated ...
Ishihara test chart book for color blindness. 14 plate. A simple accurate method for discovering congenital color blindness....
Ishihara 14 plate color vision testing set. Suitable for screening purposes....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Medicine Products: